Literature DB >> 9728564

Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats.

R Malley1, A M Stack, M L Ferretti, C M Thompson, R A Saladino.   

Abstract

To evaluate the effect of passive immunization with anticapsular antibodies on nasopharyngeal carriage, two models of Streptococcus pneumoniae colonization were developed in infant rats. In a direct inoculation model, 3- to 4-day-old infant rats were intranasally inoculated with 2 x 10(5) cfu of S. pneumoniae type 3 or 6 x 10(3) cfu of S. pneumoniae type 23F. In an intralitter transmission model, 2 infant rats were intranasally inoculated with 10(3) cfu of pneumococcus type 3 or type 19F and placed in a cage containing 10 infant rats. Pretreatment with bacterial polysaccharide immune globulin led to a significant reduction in colonization of contact animals with S. pneumoniae type 3 or 19F in the intralitter transmission model (P < .05). No effect of immune globulin could be demonstrated in the direct inoculation model. These results indicate that systemic anticapsular antibodies conferred significant protection against nasopharyngeal acquisition by intralitter spread of S. pneumoniae type 3 and 19F.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9728564     DOI: 10.1086/597600

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva.

Authors:  A Nurkka; J Obiero; H Käyhty; J A G Scott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

2.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Authors:  Richard Malley; Krzysztof Trzcinski; Amit Srivastava; Claudette M Thompson; Porter W Anderson; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance.

Authors:  Jamie K Lemon; Megan R Miller; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

Review 4.  Mechanisms of Bacterial Colonization of the Respiratory Tract.

Authors:  Steven J Siegel; Jeffrey N Weiser
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

5.  Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.

Authors:  B Benaissa-Trouw; D J Lefeber; J P Kamerling; J F Vliegenthart; K Kraaijeveld; H Snippe
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model.

Authors:  Krzysztof Trzcinski; Claudette Thompson; Richard Malley; Marc Lipsitch
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Authors:  K B Kiser; J M Cantey-Kiser; J C Lee
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  A rhesus macaque model of Streptococcus pneumoniae carriage.

Authors:  M T Philipp; L A Doyle; D S Martin; G B Plauché; K M Phillippi-Falkenstein; R P Bohm
Journal:  J Med Primatol       Date:  2011-10-04       Impact factor: 0.667

9.  Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus.

Authors:  Perla J Martinez; Christine Mathews; Jeffrey K Actor; Shen-An Hwang; Eric L Brown; Heather K De Santiago; Susan P Fisher Hoch; Joseph B McCormick; Shaper Mirza
Journal:  Transl Res       Date:  2013-08-05       Impact factor: 7.012

10.  Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.

Authors:  Inci Yildirim; William P Hanage; Marc Lipsitch; Kimberly M Shea; Abbie Stevenson; Jonathan Finkelstein; Susan S Huang; Grace M Lee; Ken Kleinman; S I Pelton
Journal:  Vaccine       Date:  2010-10-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.